The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Episodes
Mentioned books

Apr 2, 2020 • 20min
Rheumatology Author Interview: Bone Homeostasis
Timo Gaber and Paula Hoff from Charité Berlin.
Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, the impact of tofacitinib on the bone healing process is discussed.

Mar 27, 2020 • 23min
Rheumatology Author Prof Georg Schett: Osteoblasts
Prof Schett from University of Erlangen-Nuremberg.
Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.

Mar 23, 2020 • 8min
Discussing Rheumatology: JAKi and Bone Biology
Prof Iain McInnes discusses bone homeostasis.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Mar 11, 2020 • 13min
Perspectives in Inflammation - Prof Iain McInnes
Muirhead Professor of Medicine, President of EULAR, and Sir James Black Prize Medal winner. In this podcast, Prof Iain McInnes discusses the inception of JAK inhibitors during his time at the National Institutes of Health with Prof Peter Nash from the University of Queensland.
Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Feb 26, 2020 • 20min
Rheumatology Author Dr Orsolini: Osteoimmunology
Dr Giovanni Orsolini from the University of Verona.
Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Giovanni Orsolini discusses the potential of JAK inhibitors to halt bone erosion, independent of their effects on inflammation.

Feb 21, 2020 • 12min
Discussing Rheumatology: JAK Selectivity
Prof Iain McInnes discusses JAK selectivity.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Feb 7, 2020 • 14min
Perspectives in Inflammation - Prof Anca Catrina
Head of the Division of Rheumatology at Karolinska Institute and a co-author of more than 100 articles in peer review journals. In this podcast, Prof Anca Catrina discusses the role of antibodies in the pathogenesis of RA with Prof Johannes Bijlsma from University Medical Centre, Utrecht.
Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Jan 29, 2020 • 33min
Rheumatology Author Prof Vibeke Strand: PROs
Prof Vibeke Strand from Stanford University.
Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Vibeke Strand discusses improvements in patient-reported outcomes with upadacitinib.

Jan 22, 2020 • 10min
Discussing Rheumatology: Tofacitinib Improves PROs
Iain McInnes discusses patient-reported outcomes.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Jan 8, 2020 • 16min
Perspectives In Inflammation - Prof Kevin Winthrop
Member of the US Centers for Disease Control and a co-author of more than 100 publications. In this podcast, Prof Kevin Winthrop discusses the impact concomitant treatments have on HZ risk with Professor Maurizio Cutolo from the University of Genova.
Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.


